The need to rapidly develop both a preventive and therapeutic intervention against COVID-19 has propelled the pharmaceutical industry into action. The demand for the reduction in study build times requires agile adoption of technology, process, and resources. Speed,...
COVID-19 has ushered in new challenges when conducting clinical trials, but mid-tier biotech companies have different needs than large pharmaceutical companies. When companies are conducting studies for therapeutic areas such as oncology, or clinical trials for...
Wanting to learn about the benefits of managing global studies with regional partners? Tune in to the Endpoints News webinar below sponsored by Catalyst and Novotech and featuring CE3 Inc.’s Julie Bowman and Leap Therapeutics. In this webinar, you’ll learn...
Catalyst Clinical Research had the opportunity to exhibit at Arena International Event Group’s Outsourcing in Clinical Trials USA Virtual Experience 2020. Additionally, our experts participated in a panel discussion on decentralized trials, discussing their use...
Triumph Research Intelligence is asking industry leaders from Sponsors and CROs five thought-provoking questions about how COVID has changed their business. Everyone has a different story to tell and each has fascinating and valuable insights. “Accelerated...
The unusual times surrounding the global COVID-19 pandemic have impacted businesses in healthcare and beyond. Jason Layton from Jacobs Capital hosted a webinar last month with three local healthcare CEOs to learn what this meant for their industry. In the below...
